Form 8-K - Current report:
SEC Accession No. 0001213900-24-096804
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:10
Documents
15
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0220593-8k_therap.htm   iXBRL 8-K 27035
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 12, 2024, ENTITLED "THER ea022059301ex99-1_therape.htm EX-99.1 14218
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4544
  Complete submission text file 0001213900-24-096804.txt   225946

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE txmd-20241112.xsd EX-101.SCH 3036
5 XBRL LABEL FILE txmd-20241112_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE txmd-20241112_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0220593-8k_therap_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 241448342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)